Accession Number:

ADA199765

Title:

ADP (Automated Data Processing) Systems: FDA (Food and Drug Administration) Can Reduce Development Risks for Its Import Information System

Descriptive Note:

Corporate Author:

GENERAL ACCOUNTING OFFICE WASHINGTON DC INFORMATION MANAGEMENT AND TECHNOLOGY DIV

Personal Author(s):

Report Date:

1988-09-01

Pagination or Media Count:

31.0

Abstract:

As you know, The Food and Drug Administration is developing the Import Support and Information System ISIS to support its import enforcement staff and improve the efficiency and effectiveness of import operations. FDA plans to develop ISIS in stages. The basic system will be developed during the initial stage and is primarily intended to 1 track products that are wharf examined, automatically detained, or sampled and tested for compliance with regulations 2 maintain a historical database, and 3 provide office automation capabilities. FDA has prepared a system design document outlining the initial stage and plans to enhance the system in later stages. FDA estimates fiscal year 1988 funding for ISIS to be 1.6 million for software development and computer hardware. In preparing its initial plans for ISIS, FDA had not followed some important automated systems development practices that are required by the Department of Health and Human Services HHS. These practices are consistent with Federal Information Processing Standards. However, in finalizing its plans to develop ISIS, FDA has not taken three important steps required by HHS. These required steps are aimed at increasing the probability that FDA will 1 competitively procure hardware and software that will achieve its functional requirements, 2 design and implement a system that will achieve its interface requirements, and 3 select the most appropriate system design to achieve its mission requirements.

Subject Categories:

  • Information Science

Distribution Statement:

APPROVED FOR PUBLIC RELEASE